Auditing the safety and efficacy of interventional septal reduction therapies in hypertrophic obstructive cardiomyopathy at a specialized tertiary centre

Back

EHRA Premium Access

Auditing the safety and efficacy of interventional septal reduction therapies in hypertrophic obstructive cardiomyopathy at a specialized tertiary centre

Session: Ventricular Arrhythmias and SCD - Round 5 - Others

Topic: Congenital Heart Disease and Paediatric Cardiology, Other

Speaker: Miss M. Sorbini (London, GB)

Event: EHRA 2023

Congress Presentation

Add to my library

About the speaker

Miss Michela Sorbini

St Bartholomews and Queen Mary University, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

7 more presentations in this session

Cardiogenetics and Artificial Intelligence: the Mutscore Algorithm

Speaker: Doctor A. Porretta (Lausanne, CH)

Access

Abstract

Slides

Optimization of the clinical workflow and patient pathway in cardiac monitor implantation and follow-up

Speaker: Doctor V. Vanhala (Tampere, FI)

Access

Abstract

Slides

Mortality and ventricular arrhythmias in patients with atrial fibrillation on sotalol

Speaker: Doctor H. Lenhoff (Stockholm, SE)

Access

Abstract

Slides

Implementation and first outcomes of a novel SOP for preprocedural transesophageal echocardiography screening in course of atrial arrhythmia ablation

Speaker: Mr S. Dittrich (Leiden, NL)

Access

Abstract

Slides

Multi-modal physiological parameter for mapping ablation lesions

Speaker: Mr S. Masse (Toronto, CA)

Access

Abstract

Slides

Access the full session

Ventricular Arrhythmias and SCD - Round 5 - Others

Speakers: Miss M. Sorbini, Doctor A. Porretta, Doctor V. Vanhala, Doctor H. Lenhoff, Mr S. Dittrich...

Access

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources